3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Small Cell Lung Carcinoma
9
Carcinoma, Non-Small-Cell Lung
7
Sarcoma
5
Breast Neoplasms
4
Triple Negative Breast Neoplasms
3
Nasopharyngeal Carcinoma
3
Thyroid Neoplasms
2
Pancreatic Neoplasms
2
Neoplasm Metastasis
2
Esophageal Squamous Cell Carcinoma
2
Carcinoma, Renal Cell
2
Carcinoma, Hepatocellular
2
Whole-Brain Radiotherapy
1
Stomach Neoplasms
1
Solid Tumors
1
Small Cell Lung Cancer Extensive Stage
1
Sarcoma, Synovial
1
Sarcoma, Alveolar Soft Part
1
Recurrence
1
Proteinuria
1
Progression Free Survival(PFS)
1
Platinum-resistant Ovarian Cancer (PROC)
1
Ovarian Neoplasms
1
Lung Neoplasms
1
Leiomyosarcoma
1
HER2-Negative Breast Cancer
1
Gallbladder Neoplasms
1
Fallopian Tube Neoplasms
1
Extensive Stage Lung Small Cell Cancer
1
Esophageal Neoplasms
1
Interventions
Radiosurgery
50
Magnetic Resonance Spectroscopy
34
Temozolomide
28
Bevacizumab
24
pembrolizumab
23
Radiotherapy
20
Nivolumab
20
Specimen Handling
14
Ipilimumab
13
Cyclophosphamide
13
Mental Status and Dementia Tests
12
Carboplatin
12
abemaciclib
10
Radiation
10
trastuzumab deruxtecan
8
Proton Therapy
7
Pemetrexed
7
Memantine
7
Blood Specimen Collection
7
fluciclovine F-18
6
binimetinib
6
Paclitaxel
6
Lomustine
6
Etoposide
6
Cisplatin
6
Capecitabine
6
encorafenib
5
Trastuzumab
5
Surveys and Questionnaires
5
Surgical Procedures, Operative
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Brain Neoplasms
×
anlotinib
×
1 year
×
Clear all
No trials found.